CGL
BIIB icon

Clarius Group LLC’s Biogen BIIB Stock Holding History

Clarius Group LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,123
Closed -$291K – 486
2023
Q4 		$291K Buy
1,123
+60
+6% +$14.7K 0.02% 359
2023
Q3 		$273K Sell
1,063
-350
-25% -$93.6K 0.03% 361
2023
Q2 		$402K Buy
1,413
+112
+9% +$33.3K 0.03% 310
2023
Q1 		$362K Sell
1,301
-101
-7% -$27.9K 0.03% 329
2022
Q4 		$388K Buy
1,402
+26
+2% +$7.34K 0.03% 307
2022
Q3 		$367K Buy
1,376
+258
+23% +$54.8K 0.04% 287
2022
Q2 		$228K Sell
1,118
-191
-15% -$39K 0.02% 405
2022
Q1 		$314K Hold
1,309
– – 0.02% 348
2021
Q4 		$314K Sell
1,309
-253
-16% -$65.1K 0.02% 348
2021
Q3 		$442K Buy
1,562
+5
+0.3% +$1.64K 0.04% 240
2021
Q2 		$539K Sell
1,557
-21
-1% -$6.36K 0.05% 198
2021
Q1 		$441K Buy
1,578
+298
+23% +$80.4K 0.04% 216
2020
Q4 		$313K Sell
1,280
-45
-3% -$11.6K 0.03% 254
2020
Q3 		$376K Sell
1,325
-247
-16% -$68.9K 0.05% 181
2020
Q2 		$421K Buy
1,572
+283
+22% +$85.1K 0.06% 161
2020
Q1 		$408K Buy
1,289
+39
+3% +$11.8K 0.08% 131
2019
Q4 		$366K Buy
1,250
+135
+12% +$37.5K 0.06% 167
2019
Q3 		$260K Buy
1,115
+183
+20% +$42.6K 0.05% 217
2019
Q2 		$218K Sell
932
-156
-14% -$36K 0.04% 228
2019
Q1 		$257K Buy
+1,088
New +$343K 0.06% 163

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clarius Group LLC's BIIB Position: Q1 2024 in Review

Clarius Group LLC sold out of Biogen (BIIB) in Q1 2024, closing a stake of 1,123 shares — an estimated $291K sold.

Clarius Group LLC first reported a position in BIIB in Q1 2019 and held it in 20 quarters. The position peaked at $539K in Q2 2021. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Clarius Group LLC reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Clarius Group LLC sold 1,123 Biogen shares in Q1 2024, an estimated $291K.
  • Clarius Group LLC first reported a position in Biogen in Q1 2019 and held it in 20 quarters.
  • Clarius Group LLC's Biogen position peaked at $539K in Q2 2021.
  • 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Clarius Group LLC's 13F filing for Q1 2024, filed 17 Apr 2024.